4 Temporal Lobe Epilepsy Clinical Trials in Los Angeles, CA (2026)

Q: How do I join a clinical trial in Los Angeles?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you.

Recruiting Temporal Lobe Epilepsy Studies in Los Angeles

NCT05976763Recruiting

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

This phase III trial tests whether continuous or intermittent zanubrutinib after achieving a complete remission (CR) with rituximab works in older adult patients with mantle cell lymphoma (MCL) who ha...

Los Angeles, CAPHASE3421 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT06084936Recruiting

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide with rituximab (R-Len...

Los Angeles, CAPHASE3182 participantsHoffmann-La Roche

View Study Details

NCT06252675Recruiting

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

This phase II trial tests the safety and effectiveness of glofitamab given in combination with pirtobrutinib in treating patients with mantle cell lymphoma that has come back after a period of improve...

Los Angeles, CAPHASE230 participantsUniversity of California, San Francisco

View Study Details

NCT06422923Recruiting

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

This is a multicenter, single arm, open label clinical trial that is designed to test the safety and preliminary efficacy of single administration inhibitory nerve cells called interneurons (NRTX-1001...

Los Angeles, CAPHASE110 participantsNeurona Therapeutics

View Study Details

About Temporal Lobe Epilepsy Clinical Trials in Los Angeles

Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.

There are currently 4 temporal lobe epilepsy clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 643 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology, Hoffmann-La Roche, University of California, San Francisco and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Temporal Lobe Epilepsy Clinical Trials in Los Angeles — FAQ

Are there temporal lobe epilepsy clinical trials in Los Angeles?

Yes, there are 4 temporal lobe epilepsy clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What temporal lobe epilepsy treatments are being tested?

The 4 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for temporal lobe epilepsy.

Data updated October 15, 2026 from ClinicalTrials.gov